DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Hollander P, Hill J, Johnson J. et al.
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on Metformin.
Curr Med Res Opin 2019;
35 (08) 1335-1343
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.